Syros Pharmaceuticals Inc (NASDAQ:SYRS)

Delayed Data
As of 3:59pm ET
 -0.225 / -4.54%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Syros Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 21.00 and a low estimate of 9.00. The median estimate represents a +280.55% increase from the last price of 4.73.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Syros Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.53%
Growthannually 16.76%


Growthquarterly -13.12%
Growthannually 25.47%
Key to the earnings and sales forecast charts.